166 related articles for article (PubMed ID: 34874592)
41. Gene of the month: TFE 3.
Pinto K; Chetty R
J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
[TBL] [Abstract][Full Text] [Related]
42. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
[No Abstract] [Full Text] [Related]
43. Novel NONO::TFE3 fusion and ALK co-expression identified in a subset of cutaneous microcystic/reticular schwannoma.
Fritchie KJ; Dermawan JK; Astbury C; Sharma A; Bakhshwin A; Fuller L; Agrawal S; Wieland CN; Greipp PT; Azzato EM; Folpe AL; Billings SD
Virchows Arch; 2023 Aug; 483(2):237-243. PubMed ID: 37468653
[TBL] [Abstract][Full Text] [Related]
44. Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.
Wang XT; Xia QY; Ni H; Wang ZY; Ye SB; Li R; Wang X; Lv JH; Shi SS; Ma HH; Lu ZF; Shen Q; Zhou XJ; Rao Q
Histopathology; 2016 Sep; 69(3):450-8. PubMed ID: 26844676
[TBL] [Abstract][Full Text] [Related]
45. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
[TBL] [Abstract][Full Text] [Related]
46. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
47. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
[TBL] [Abstract][Full Text] [Related]
48. Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement.
Zhong M; Weisman P; Zhu B; Brassesco M; Yang Y; Linehan WM; Merino MJ; Zhang D; Rohan S; Cai D; Yang X
Diagn Mol Pathol; 2013 Jun; 22(2):107-11. PubMed ID: 23628822
[TBL] [Abstract][Full Text] [Related]
49. Is immunohistochemistry always the panacea to morphologic mimics? Two, distinct soft tissue tumors exhibiting alveolar pattern and TFE3 immunoreactivity.
Shah A; Rekhi B; Patil A
Indian J Pathol Microbiol; 2021; 64(4):767-770. PubMed ID: 34673600
[TBL] [Abstract][Full Text] [Related]
50. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.
Neumann NM; Haffner MC; Argani P; Kao CS; Epstein JI
Am J Surg Pathol; 2021 Feb; 45(2):169-177. PubMed ID: 33002920
[TBL] [Abstract][Full Text] [Related]
51. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification.
Wang XT; Xia QY; Zhou XJ; Rao Q
Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
[TBL] [Abstract][Full Text] [Related]
52. Epithelioid hemangioendothelioma (EHE) with WWTR1::TFE3 gene fusion, a novel fusion variant.
Li S; Dermawan JK; Seavey CN; Ma S; Antonescu CR; Rubin BP
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23226. PubMed ID: 38380774
[TBL] [Abstract][Full Text] [Related]
53. Subungual Acral Fibromyxoma Involving the Bone: A Mimicker of Malignancy.
Carranza C; Molina-Ruiz AM; Pérez de la Fuente T; Kutzner H; Requena L; Santonja C
Am J Dermatopathol; 2015 Jul; 37(7):555-9. PubMed ID: 25062265
[TBL] [Abstract][Full Text] [Related]
54. Cutaneous PEComa does not harbour TFE3 gene fusions: immunohistochemical and molecular study of 17 cases.
Llamas-Velasco M; Mentzel T; Requena L; Palmedo G; Kasten R; Kutzner H
Histopathology; 2013 Jul; 63(1):122-9. PubMed ID: 23711163
[TBL] [Abstract][Full Text] [Related]
55. [Perivascular epithelioid cell tumor of the lung: a clinicopathological analysis of eight cases].
Li J; Huang RP; Pang P; Guo X; Wang YH; Guo LC; Huang S
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1126-1131. PubMed ID: 37899318
[No Abstract] [Full Text] [Related]
56. Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.
Liu F; Zhang R; Wang ZY; Xia Q; Shen Q; Shi S; Tu P; Shi Q; Zhou X; Rao Q
Int J Clin Exp Pathol; 2014; 7(9):6409-14. PubMed ID: 25337301
[TBL] [Abstract][Full Text] [Related]
57. A case of PSF-TFE3 gene fusion in Xp11.2 renal cell carcinoma with melanotic features.
Zhan HQ; Chen H; Wang CF; Zhu XZ
Hum Pathol; 2015 Mar; 46(3):476-81. PubMed ID: 25582502
[TBL] [Abstract][Full Text] [Related]
58. Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE).
Hirobe M; Masumori N; Tanaka T; Kitamura H; Tsukamoto T
Cancer Biol Ther; 2013 Jun; 14(6):502-10. PubMed ID: 23760492
[TBL] [Abstract][Full Text] [Related]
59. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression.
Zhao M; Rao Q; Wu C; Zhao Z; He X; Ru G
Diagn Pathol; 2015 Sep; 10():160. PubMed ID: 26369552
[TBL] [Abstract][Full Text] [Related]
60. TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.
Schoolmeester JK; Dao LN; Sukov WR; Wang L; Park KJ; Murali R; Hameed MR; Soslow RA
Am J Surg Pathol; 2015 Mar; 39(3):394-404. PubMed ID: 25517951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
